골이식재 및 골대체재 시장 규모, 점유율, 동향 분석 보고서 : 소재별, 용도별, 지역별, 부문별 예측(2026-2033년)

Bone Grafts And Substitutes Market Summary

The global bone grafts and substitutes market size was estimated at USD 3.34 billion in 2025 and is projected to reach USD 5.50 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. Increasing utilization of bone grafts and substitutes in various applications such as spinal fusion, orthopedic fracture healing, periodontal defect repair, dental alveolar ridge augmentation, and wound care with skin equivalents primarily drives the growth of this market.

Significant technological advancements, the emergence of synthetic bone grafts, the availability of novel surgical solutions, and substantial changes in regenerative medicine are expected to develop lucrative growth opportunities for the bone grafts and substitutes market.

Increasing demand for synthetic bone grafts, primarily driven by factors such as risks of infection and limited supply, has stimulated new product developments and growing efforts focused on R&D associated with bone grafts. Moreover, the launch of innovation-based solutions by prominent manufacturers indicates the growth potential of this market. For instance, in December 2025, Xtant Medical Holdings, Inc., a surgical solutions provider for spinal and other orthopedic conditions, announced the launch of its latest offering, nanOss strata-synthetic bone graft, which is developed with hydroxycarbonapatite (HCA), a material characterized by higher solubility as compared to traditional hydroxyapatite. Such developments are likely to support industry growth in the forecast period.

The increasing use of bone grafts in dentistry is adding to the growth potential of the dental bone grafts and substitutes market. Furthermore, dental implant surgery has become very popular with advanced surgical techniques, such as bone grafts and bone regeneration. Moreover, dental implants are the most preferred solution for individuals experiencing tooth-based conditions. both practitioner skills and the emerging technology supporting dental implants continue to evolve.

However, shifting trends and inclination among dental practitioners towards offering convenience without compromising patient safety, multiple manufacturers in this industry have been adding innovative products to their product lines. For instance, in February 2025, one of the key participants in regenerative medicine and the life sciences industry, LifeNet Health, introduced OraGen, a viable dental bone allograft, equipped with cryopreserved corticocancellous bone comprising endogenous lineage. Such product launches and accessibility to solutions that improve the effectiveness of dental procedures are projected to fuel the market growth.

Some of the key technological advancements expected to boost market growth are:

Development of patient-specific, customized scaffolds using 3D printing.

Use of bioactive peptides, which enable natural healing while significantly reducing the risk of unwanted ectopic bone growth.

Digital integration, imaging-guided surgeries, and the use of AI-powered tools ensure precise procedures while ensuring lower recovery time.

Furthermore, a supportive regulatory framework is anticipated to support the bone grafts and substitutes market potential. For instance, the Breakthrough Device Program by the U.S. FDA focuses on helping the acceleration of development and review of innovative devices that offer enhanced treatments for lethal or irreversibly debilitating medical conditions. In October 2024, Amphix Bio, a company engaged in the development of regenerative medicine, announced that the FDA granted Breakthrough Device designation to its off-the-shelf bone graft substitute, AMFX 100. Such advancements and supportive government programs are fueling the market growth.

Rising adoption of minimally invasive procedures is further escalating the demand for bone grafts and substitutes. Surgeons are choosing minimally invasive procedures instead of open or traditional approaches owing to various benefits associated with MIS, such as quick procedure, less recovery time, shorter hospital stays, and fewer incisions. According to data from the American Academy of Orthopedic Surgeons (AAOS), the number of minimally invasive orthopedic procedures performed in the U.S. has been increasing steadily over the years. Some of the commonly performed minimally invasive orthopedic procedures in the U.S. are arthroscopy, spine surgeries, fracture repair, and joint replacement procedures. Thus, a rising number of MIS is anticipated to drive the global bone grafts and substitutes market at a significant pace.

The increasing incidence of bone disorders due to road accidents and sports injuries is driving the bone grafts and substitutes industry. Bone grafts can be used for the following purposes:

To repair a broken bone

To repair previously injured bone that has not healed.

Spinal fusion (in case of an unstable spine)

Bone regeneration

To heal the bone around surgical implantation (joint & knee replacement)

Global Bone Grafts And Substitutes Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bone grafts and substitutes market report based on material type, application, and region:

• Material Type Outlook (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)
• Allograft
  • Demineralised Bone Matrix
  • Others
• Synthetic
  • Ceramics
  • HAP
  • B-TCP
  • a-TCP
  • bi-phasic calcium phosphates (BCP)
  • Others (calcium sulphates, tricalcium phosphate)
  • Composites
  • Polymers
  • Bone Morphogenic Proteins (BMP)
• Application Outlook (Revenue USD Million, 2021 - 2033)
• Craniomaxilofacial
• Dental
• Foot and Ankle
• Joint Reconstruction
• Long Bone
• Spinal Fusion
• Regional Outlook (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Segment Definitions
  • 1.2.1 Material Type Segment
  • 1.2.2 Application Segment
• 1.3 Research Methodology
• 1.4 Information Procurement
  • 1.4.1 Purchased database
  • 1.4.2 GVR's Internal Database
  • 1.4.3 Secondary sources
  • 1.4.4 Primary Research:
  • 1.4.5 Details of Primary Research
    • 1.4.5.1 Data for Primary Interviews in North America
    • 1.4.5.2 Data for Primary Interviews in Europe
    • 1.4.5.3 Data for Primary Interviews in Asia Pacific
    • 1.4.5.4 Data for Primary Interviews in Latin America
    • 1.4.5.5 Data for Primary Interviews in Middle East and Africa
• 1.5 Information or Data Analysis
  • 1.5.1 Data Analysis Models
• 1.6 Market Formulation & Validation
• 1.7 Model Details
  • 1.7.1 Commodity Flow Analysis
    • 1.7.1.1 Approach: Commodity Flow Approach
• 1.8 List of Secondary Sources
• 1.9 List of Primary Sources
• 1.10 Abbreviations
• 1.11 Report Objectives
• 1.12 Research Methodology for Bone Grafts and Substitutes Market
  • 1.12.1 Research Scope and Assumptions for Bone Grafts and Substitutes Market
  • 1.12.2 Research Methodology and Assumptions

Chapter 2 Executive Summary

• 2.1 Bone Grafts and Substitutes Market Snapshot
• 2.2 Bone Grafts and Substitutes Market Snapshot
• 2.3 Bone Grafts and Substitutes Market Competitive Landscape Snapshot

Chapter 3 Bone Grafts and Substitutes Market Variables and Trends

• 3.1 Market Lineage Outlook
  • 3.1.1 Ancillary/Related Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Rising Incidence of Bone & Joint Disorders
    • 3.2.1.2 Advent of Biocompatible Synthetic Graft
    • 3.2.1.3 Rising Demand for Dental Bone Grafts
    • 3.2.1.4 Technological Advancements
    • 3.2.1.5 Rising Geriatric Population
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Stringent Regulatory Guidelines
    • 3.2.2.2 Risk of Disease Transmission
• 3.3 Bone Grafts and Substitutes Market Analysis Tools
  • 3.3.1 Industry Analysis - PORTER'S
  • 3.3.2 Industry Analysis - PESTLE
• 3.4 Bone Grafts and Substitute Industry: Product Pipeline Analysis
• 3.5 Types of Dental Surgeries Utilizing Non-Metal Dental Implants
• 3.6 Case Study Analysis

Chapter 4 Bone Grafts and Substitutes Market: Material Type Estimates & Trend Analysis (Revenue in USD Million, Unit Volume in Thousand Units)

• 4.1 Bone Grafts and Substitutes Market: Material Type Outlook Key Takeaways
• 4.2 Bone Grafts and Substitutes Market: Material Type Movement Analysis
• 4.3 Allograft
  • 4.3.1 Allograft Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
  • 4.3.2 Demineralized Bone Matrix (DBM)
    • 4.3.2.1 Demineralized Bone Matrix (DBM) Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
  • 4.3.3 Others
    • 4.3.3.1 Others Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
• 4.4 Synthetic
  • 4.4.1 Synthetic Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
  • 4.4.2 Ceramic
    • 4.4.2.1 Ceramic Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
    • 4.4.2.2 HAP
      • 4.4.2.2.1 HAP Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
    • 4.4.2.3 B-TCP
      • 4.4.2.3.1 B-TCP Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
    • 4.4.2.4 a-TCP
      • 4.4.2.4.1 a-TCP Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
    • 4.4.2.5 Bi-Phasic Calcium Phosphates (BCP)
      • 4.4.2.5.1 Bi-Phasic Calcium Phosphates (BCP) Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
    • 4.4.2.6 Others
      • 4.4.2.6.1 Others Market Estimates And Forecasts, 2021- 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
  • 4.4.3 Composite
    • 4.4.3.1 Composite Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
  • 4.4.4 Polymers
    • 4.4.4.1 Polymers Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
  • 4.4.5 Bone Morphogenic Proteins (BMP)
    • 4.4.5.1 BMP Market Estimates And Forecasts, 2021 - 2033 (Revenue in USD Million, Unit Volume in Thousand Units)

Chapter 5 Bone Grafts and Substitutes Market: Application Estimates & Trend Analysis

• 5.1 Bone Grafts and Substitutes Market: Application Outlook Key Takeaways
• 5.2 Bone Grafts and Substitutes Market: Application Movement Analysis
• 5.3 Craniomaxillofacial
  • 5.3.1 Craniomaxillofacial Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.4 Dental
  • 5.4.1 Dental Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.5 Foot and Ankle
  • 5.5.1 Foot and Ankle Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.6 Joint Reconstruction
  • 5.6.1 Joint Reconstruction Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.7 Long Bone
  • 5.7.1 Long Bone Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.8 Spinal Fusion
  • 5.8.1 Spinal Fusion Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 6 Bone Grafts and Substitutes Market: Regional Estimates & Trend Analysis

• 6.1 Bone Grafts and Substitutes Market: Regional Key takeaways
• 6.2 Bone Grafts and Substitutes Market, by Region, 2026 & 2033, (Revenue in USD Million, Unit Volume in Thousand Units)
• 6.3 North America
  • 6.3.1 North America Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.3.2 U.S.
    • 6.3.2.1 Key country dynamics
    • 6.3.2.2 Regulatory Framework
    • 6.3.2.3 Competitive Scenario
    • 6.3.2.4 U.S. Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.3.3 Canada
    • 6.3.3.1 Key country dynamics
    • 6.3.3.2 Regulatory Framework
    • 6.3.3.3 Competitive Scenario
    • 6.3.3.4 Canada Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.3.4 Mexico
    • 6.3.4.1 Key country dynamics
    • 6.3.4.2 Regulatory Framework
    • 6.3.4.3 Competitive Scenario
    • 6.3.4.4 Mexico Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
• 6.4 Europe
  • 6.4.1 Europe Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.4.2 UK
    • 6.4.2.1 Key country dynamics
    • 6.4.2.2 Regulatory Framework
    • 6.4.2.3 Competitive Scenario
    • 6.4.2.4 UK Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.4.3 Germany
    • 6.4.3.1 Key country dynamics
    • 6.4.3.2 Regulatory Framework
    • 6.4.3.3 Competitive Scenario
    • 6.4.3.4 Germany Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.4.4 France
    • 6.4.4.1 Key country dynamics
    • 6.4.4.2 Regulatory Framework
    • 6.4.4.3 Competitive Scenario
    • 6.4.4.4 France Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.4.5 Spain
    • 6.4.5.1 Key country dynamics
    • 6.4.5.2 Regulatory Framework
    • 6.4.5.3 Competitive Scenario
    • 6.4.5.4 Spain Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.4.6 Italy
    • 6.4.6.1 Key country dynamics
    • 6.4.6.2 Regulatory Framework
    • 6.4.6.3 Competitive Scenario
    • 6.4.6.4 Italy Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.4.7 Denmark
    • 6.4.7.1 Key country dynamics
    • 6.4.7.2 Regulatory Framework
    • 6.4.7.3 Competitive Scenario
    • 6.4.7.4 Denmark Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.4.8 Sweden
    • 6.4.8.1 Key country dynamics
    • 6.4.8.2 Regulatory Framework
    • 6.4.8.3 Competitive Scenario
    • 6.4.8.4 Sweden Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.4.9 Norway
    • 6.4.9.1 Key country dynamics
    • 6.4.9.2 Regulatory Framework
    • 6.4.9.3 Competitive Scenario
    • 6.4.9.4 Norway Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
• 6.5 Asia Pacific
  • 6.5.1 Asia Pacific Bone Grafts and Substitutes Market Estimates and Forecasts(Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.5.2 Japan
    • 6.5.2.1 Key country dynamics
    • 6.5.2.2 Regulatory Framework
    • 6.5.2.3 Competitive Scenario
    • 6.5.2.4 Japan Bone Grafts and Substitutes Market Estimates and Forecasts(Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.5.3 China
    • 6.5.3.1 Key country dynamics
    • 6.5.3.2 Regulatory Framework
    • 6.5.3.3 Competitive Scenario
    • 6.5.3.4 China Bone Grafts and Substitutes Market Estimates and Forecasts(Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.5.4 India
    • 6.5.4.1 Key country dynamics
    • 6.5.4.2 Regulatory Framework
    • 6.5.4.3 Competitive Scenario
    • 6.5.4.4 India Bone Grafts and Substitutes Market Estimates and Forecasts(Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.5.5 Australia
    • 6.5.5.1 Key country dynamics
    • 6.5.5.2 Regulatory Framework
    • 6.5.5.3 Competitive Scenario
    • 6.5.5.4 Australia Bone Grafts and Substitutes Market Estimates and Forecasts(Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.5.6 Thailand
    • 6.5.6.1 Key country dynamics
    • 6.5.6.2 Regulatory Framework
    • 6.5.6.3 Competitive Scenario
    • 6.5.6.4 Thailand Bone Grafts and Substitutes Market Estimates and Forecasts(Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.5.7 South Korea
    • 6.5.7.1 Key country dynamics
    • 6.5.7.2 Regulatory Framework
    • 6.5.7.3 Competitive Scenario
    • 6.5.7.4 South Korea Bone Grafts and Substitutes Market Estimates and Forecasts, 2021- 2033 (Revenue in USD Million, Unit Volume in Thousand Units)
• 6.6 Latin America
  • 6.6.1 Latin America Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.6.2 Brazil
    • 6.6.2.1 Key country dynamics
    • 6.6.2.1 Regulatory Framework
    • 6.6.2.2 Competitive Scenario
    • 6.6.2.3 Brazil Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.6.3 Argentina
    • 6.6.3.1 Key country dynamics
    • 6.6.3.2 Regulatory Framework
    • 6.6.3.3 Competitive Scenario
    • 6.6.3.4 Argentina Bone Grafts and Substitutes Market Estimates and Forecasts(Revenue in USD Million, Unit Volume in Thousand Units)
• 6.7 Middle East & Africa (MEA)
  • 6.7.1 MEA Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.7.2 South Africa
    • 6.7.2.1 Key country dynamics
    • 6.7.2.2 Regulatory Framework
    • 6.7.2.3 Competitive Scenario
    • 6.7.2.4 South Africa Bone Grafts and Substitutes market estimates and forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.7.3 Saudi Arabia
    • 6.7.3.1 Key Country Dynamics
    • 6.7.3.2 Regulatory Framework
    • 6.7.3.3 Competitive Scenario
    • 6.7.3.4 Saudi Arabia Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.7.4 UAE
    • 6.7.4.1 Key country dynamics
    • 6.7.4.2 Regulatory Framework
    • 6.7.4.3 Competitive Scenario
    • 6.7.4.4 UAE Bone Grafts and Substitutes Market Estimates and Forecasts(Revenue in USD Million, Unit Volume in Thousand Units)
  • 6.7.5 Kuwait
    • 6.7.5.1 Key country dynamics
    • 6.7.5.2 Regulatory Framework
    • 6.7.5.3 Competitive Scenario
    • 6.7.5.4 Kuwait Bone Grafts and Substitutes Market Estimates and Forecasts (Revenue in USD Million, Unit Volume in Thousand Units)

Chapter 7 Bone Grafts and Substitutes Market: Competitive Landscape

• 7.1 Recent Developments
• 7.2 Company Categorization
• 7.3 AlloSource
  • 7.3.1 Participants' Overview
  • 7.3.2 Product Benchmarking
  • 7.3.3 Financial Performance
  • 7.4.4 Strategy Mapping
• 7.4 DePuy Synthes (Johnson & Johnson)
  • 7.4.1 Participants' Overview
  • 7.4.2 Product Benchmarking
  • 7.4.4 Financial Performance
  • 7.4.4 Strategy Mapping
• 7.5 Baxter
  • 7.5.1 Participants' Overview
  • 7.5.2 Product Benchmarking
  • 7.5.3 Financial Performance
  • 7.5.4 Strategy Mapping
• 7.6 NuVasive, Inc.
  • 7.6.1 Participants' Overview
  • 7.6.2 Product Benchmarking
  • 7.6.3 Financial Performance
  • 7.6.4 Strategy Mapping
• 7.7 Smith + Nephew
  • 7.7.1 Participants' Overview
  • 7.7.2 Product Benchmarking
  • 7.7.3 Financial Performance
  • 7.7.4 Strategy Mapping
• 7.8 Medtronic
  • 7.8.1 Participants' Overview
  • 7.8.2 Product Benchmarking
  • 7.8.3 Financial Performance
  • 7.8.4 Strategy Mapping
• 7.9 Orthofix Medical, Inc.
  • 7.9.1 Participants' Overview
  • 7.9.2 Product Benchmarking
  • 7.9.3 Financial Performance
  • 7.9.4 Strategy Mapping
• 7.10 OST Laboratories
  • 7.10.1 Participants' Overview
  • 7.10.2 Product Benchmarking
  • 7.10.3 Financial Performance
  • 7.10.4 Strategy Mapping
• 7.11 Zimmer Biomet
  • 7.11.1 Participants' Overview
  • 7.11.2 Product Benchmarking
  • 7.11.3 Financial Performance
  • 7.11.4 Strategy Mapping
• 7.12 Geistlich Pharma AG
  • 7.12.1 Participants' Overview
  • 7.12.2 Product Benchmarking
  • 7.12.3 Financial Performance
  • 7.12.4 Strategy Mapping
• 7.13 Stryker
  • 7.13.1 Participants' Overview
  • 7.13.2 Product Benchmarking
  • 7.13.3 Financial Performance
  • 7.13.4 Strategy Mapping
• 7.14 Biobank
  • 7.14.1 Participants' Overview
  • 7.14.2 Product Benchmarking
  • 7.14.3 Financial Performance
  • 7.14.4 Strategy Mapping